CLINICAL RADIATION ONCOLOGY
Duke University · NC · RADTHER101
CLINICAL RADIATION ONCOLOGY is a subject at Duke University, NC in [object Object]. It covers topics like cancer-biology, clinical-genetics, oncology, radiation-science. It is part of 3 degrees. The information below is compiled from public course material — approximate, not official.
Duke University
RADTHER101
3.00
[object Object]
Topics covered
Degrees that include CLINICAL RADIATION ONCOLOGY
Frequently asked questions
What is CLINICAL RADIATION ONCOLOGY about?
CLINICAL RADIATION ONCOLOGY covers topics like cancer-biology, clinical-genetics, oncology, radiation-science.
Which degrees include CLINICAL RADIATION ONCOLOGY?
CLINICAL RADIATION ONCOLOGY is part of 3 degrees, including Oncology-SCRT, Palliative Care-SCRT, Radiation Therapy.
How many credit points is CLINICAL RADIATION ONCOLOGY?
CLINICAL RADIATION ONCOLOGY at Duke University is typically around 3.00 credit points. Approximate — confirm with the university.
Where is CLINICAL RADIATION ONCOLOGY taught?
CLINICAL RADIATION ONCOLOGY is taught at Duke University, NC.
Studying CLINICAL RADIATION ONCOLOGY?
Peernovo helps students research, choose and thrive at university — across Australia, the US, the UK and Canada — powered by our AI backbone:
- Explore & compare degrees — across universities and countries with honest, specific information.
- "What Can I Be?" career guidance — an AI pathway councillor that maps degrees to careers.
- See who's studying — your degree at your university — find classmates and study groups.
- AI Task Coach — a Socratic study companion that plans your work around your life.
- Honours & Thesis Research Coach — structure and move your research project forward.
- Smart study planner, exam prep and a daily digest — to keep you on track.
Sources: Duke University public course catalogue. Information is compiled and summarised — not copied verbatim — and is approximate; always confirm with the original source.
Something not right on this page, or want it changed? Let us know and we'll review it.